ASCO: More Radiation No Good in NSCLC
CHICAGO (MedPage Today) -- Boosting the dose of radiation therapy in stage III non-small cell lung cancer actually compromises outcomes and cuts survival, a randomized trial showed.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Respiratory Medicine